Snake venom proteins acting on hemostasis

Biochimie

Volumn 82, Issue 9-10, 2000, Pages 851-859

  Braud, Sandrine ^a   Bon, Cassian ^a   Wisner, Anne ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACC C; BATROXOBIN; BLOOD CLOTTING FACTOR; BOTROCETIN; DISINTEGRIN; ECARIN; LECTIN; METALLOPROTEINASE; PHOSPHOLIPASE A2; PROTAC; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; RECEPTOR; RUSSELL VIPER VENOM; RVV X; SERINE PROTEINASE; SEROTONIN; SNAKE VENOM; UNCLASSIFIED DRUG;

BLOOD CLOTTING; BLOOD CLOTTING TEST; DRUG STRUCTURE; DRUG TARGETING; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MOLECULAR MODEL; MOLECULAR RECOGNITION; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; THROMBOCYTE;

SERPENTES; VIPER; VIPERIDAE;

EID: 0033741151     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(00)01178-0     Document Type: Review

References (65)

1. Snake venom constituents: Biochemistry and toxicology
2. Snake venom constituents: Biochemistry and toxicology
3. Snake venoms affecting the haemostatic mechanism - A consideration of their mechanisms, practical applications and biological significance
4. Physiologie et exploration de l'hemostase
5. The coagulation cascade: Initiation, maintenance, and regulation
6. The role of platelets in the early and late vascular responses initiated by mechanical vascular injury
7. Hemorrhagic metalloproteinases from snake venoms
8. Snake venom metalloproteinases and disintegrins: Interactions with cells
9. Inhibition of platelet aggregation by 5'-nucleotidase purified from Trimeresurus gramineus snake venom
10. 2 with anticoagulant activity. II. Inhibition of the phospholipid activity in coagulation
11. 2
12. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors
13. Effects of snake venom proteins on blood platelets
14. Prothrombin Houston: A dysprothrombin identifiable by crossed immunoelectrofocusing and abnormal Echis carinatus venom activation
15. Platelet aggregation and the availability of platelet factor 3
16. Thromboplastin generation: Effect of the Bell-Alton reagent and Russell viper venom on prothrombin consumption
17. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulant
18. Characterization of the protein C activator Protac from the venom of the southern copperhead (Agkistrodon contortrix) snake
19. Anticoagulant therapy with a purified fraction of Malayan pit viper venom
20. The coagulant enzyme from Bothrops atrox venom (batroxobin)
21. Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca
22. Multi-domain, cell-envelope proteinases of lactic acid bacteria
23. Macluralisin - A serine proteinase from fruits of Maclura pomifera (Raf.) Schneid
24. Evolution of proteolytic enzymes
25. Proteolytic enzymes, past and present
26. Structural basis of substrate specificity in the serine proteases
27. Evolution of proteolytic enzymes
28. Serpin-resistant mutants of human tissue-type plasminogen activator
29. Three-dimensional structure of tosyl-alpha-chymotrypsin
30. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region
31. The X-ray structures of porcine pancreatic kallikrein and of its complex with bovine pancreatic trypsin inhibitor
32. The refined 1.9 A crystal structure of human alpha-thrombin: Interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment
33. Structure of human des(1-45) factor Xa at 2.2 A resolution
34. The 2.3 angstrom crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator
35. Comparative modeling methods: Application to the family of the mammalian serine proteases
36. Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold
37. Snake venoms
38. Effect of five Thai snake venoms on coagulation, fibrinolysis and platelet aggregation
39. Cerastocytin, a new thrombin-like platelet activator from the venom of the Tunisian viper Cerastes cerastes
40. Purification, characterization, and amino acid sequence of a serine proteinase, PA-BJ, with platelet-aggregating activity from the venom of Bothrops jararaca
41. Interaction of viper venom serine peptidases with thrombin receptors on human platelets
42. Thrombocytin, a serine protease from Bothrops atrox venom. 1. Purification and characterization of the enzyme
43. Molecular properties of the factor V-activating enzyme from Russell's viper venom
44. Thrombin-like snake venom proteinases
45. Thrombin-like venom enzymes: Structure and function
46. Thrombin-like enzymes from snake venoms: An updated inventory. Scientific and Standardization Committee's Registry of Exogenous Hemostatic Factors
47. A novel plasminogen activator from snake venom. Purification, characterization, and molecular cloning
48. Organization of the gene for batroxobin, a thrombin-like snake venom enzyme. Homology with the trypsin/kallikrein gene family
49. Accelerated evolution of Crotalinae snake venom gland serine proteases
50. 2 isozymes
51. 2 isozyme genes
52. 2 isozymes
53. The crystal structure of the novel snake venom plasminogen activator TSV-PA: A prototype structure for snake venom serine proteinases
54. Trimeresurus stejnegeri snake venom plasminogen activator. Site-directed mutagenesis and molecular modeling
55. Basic and clinical aspects of fibrinolysis and thrombolysis
56. Potential approaches for therapeutic intervention of thrombosis by fibrinolytic agents
57. Effects of defibrase on fibrinogen and its derivatives in patients with vibration syndrome
58. The contribution of residues 192 and 193 to the specificity of snake venom serine proteinases
59. Thrombin specificity
60. Functional mapping of the surface residues of human thrombin
61. Reptilase-R: A new reagent in blood coagulation
62. Fibrinogen Kawaguchi: An abnormal fibrinogen characterized by defective release of fibrinopeptide A
63. Activation of human factor X (Stuart factor) by a protease from Russell's viper venom
64. Coagulation factor X-activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains